PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 5.88
-0.01 (-0.17%)
Aug 27, 2026, 4:08 PM HKT
PegBio Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Revenue | - | - | - | - | - | 0 |
Other Revenue | - | - | - | - | - | 0.24 |
| - | - | - | - | - | 0.24 | |
Revenue Growth | - | - | - | - | - | 122.72% |
Cost of Revenue | - | - | - | - | 4.76 | 0.22 |
Gross Profit | - | - | - | - | -4.76 | 0.02 |
Selling, General & Admin | 182.71 | 155.57 | 192.43 | 55.36 | 32.32 | 66.39 |
Research & Development | 133.9 | 50.39 | 95.43 | 236.73 | 95.42 | 151.03 |
Other Operating Expenses | -0.26 | -0.19 | -7.01 | -2.81 | 0.26 | 0.02 |
Operating Expenses | 316.34 | 205.77 | 280.85 | 289.28 | 128.08 | 217.47 |
Operating Income | -316.34 | -205.77 | -280.85 | -289.28 | -132.85 | -217.45 |
Interest Expense | -3.21 | -2.78 | -2.5 | -1.73 | -3.15 | -1.51 |
Interest & Investment Income | 2.62 | - | - | 5.29 | 1 | 1.03 |
Currency Exchange Gain (Loss) | -12.88 | - | - | - | -0.42 | 0.12 |
Other Non Operating Income (Expenses) | -0.38 | - | - | 0.22 | -0.18 | -0.01 |
EBT Excluding Unusual Items | -330.19 | -208.55 | -283.35 | -285.51 | -135.59 | -217.83 |
Gain (Loss) on Sale of Investments | -0.89 | - | - | 6.33 | - | - |
Other Unusual Items | - | - | - | - | 3.67 | 8.23 |
Pretax Income | -331.07 | -208.55 | -283.35 | -279.18 | -131.92 | -209.6 |
Earnings From Continuing Operations | -331.07 | -208.55 | -283.35 | -279.18 | -131.92 | -209.6 |
Minority Interest in Earnings | 0.18 | 0.19 | 0.19 | 0.18 | 1.57 | 2.81 |
Net Income | -330.89 | -208.36 | -283.16 | -279 | -130.35 | -206.79 |
Net Income to Common | -330.89 | -208.36 | -283.16 | -279 | -130.35 | -206.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 389 | 378 | 367 | 362 | 266 | - |
Shares Outstanding (Diluted) | 389 | 378 | 367 | 362 | 266 | - |
Shares Change | 5.49% | 3.19% | 1.40% | 35.93% | - | - |
EPS (Basic) | -0.85 | -0.55 | -0.77 | -0.77 | -0.49 | - |
EPS (Diluted) | -0.85 | -0.55 | -0.77 | -0.77 | -0.49 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Free Cash Flow | - | -155.57 | -184.32 | -233.9 | -189.12 | -69.04 |
Free Cash Flow Per Share | - | -0.41 | -0.50 | -0.65 | -0.71 | - |
Gross Margin | - | - | - | - | - | 9.71% |
Operating Margin | - | - | - | - | - | -89706.26% |
Profit Margin | - | - | - | - | - | -85309.15% |
Free Cash Flow Margin | - | - | - | - | - | -28482.33% |
EBITDA | -315.48 | -204.89 | -280.02 | -287.99 | -131.91 | -216.38 |
D&A For EBITDA | 0.87 | 0.88 | 0.83 | 1.3 | 0.93 | 1.07 |
EBIT | -316.34 | -205.77 | -280.85 | -289.28 | -132.85 | -217.45 |